Melica Nourmoussavi Brodeur

Jewish General Hospital, Twitter (United States)

Papers

Total Citations

H-Index

About

Melica Nourmoussavi Brodeur is a gynecologic oncologist and researcher whose work lies at the intersection of surgical innovation, obesity, and cancer outcomes. Her research focuses on how patient-specific factors—particularly body mass index (BMI)—influence both the biology and surgical management of gynecologic malignancies. In her most-cited study (8 citations), she employed a predictors-matched case-control design to demonstrate that obesity is independently associated with worse survival in epithelial ovarian cancer, even after controlling for stage, histology, and comorbidities. This work challenges conventional risk stratification and has implications for personalized treatment planning. Dr. Brodeur is also advancing the field of minimally invasive surgery. Her 2025 study on robotic-assisted gynecologic cancer surgery (2 citations) identified conversion rates and reasons for switching to laparotomy, providing critical safety benchmarks for robotic programs. Additionally, her investigation into sentinel lymph node mapping in patients with endometrial intraepithelial neoplasia (1 citation) addresses a contentious clinical debate, suggesting that nodal assessment may be feasible in obese patients undergoing robotic surgery. Together, her contributions bridge surgical technique and patient-centered outcomes, offering actionable insights for clinicians managing complex gynecologic cancers.